ior et al156 did
not report on skin burn as a complication. In the 16
studies that Alozai et al29 included in their systematic
review/meta-analysis of treatment modalities of the
AAGSV, there was a 0.7% incidence of paresthesia with
no instances of skin burn. The ablation modalities
included RFA, EVLA, n-butyl cyanoacrylate and sclerotherapy.